Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Growing number of long intergenic noncoding RNAs (lincRNAs) have recently been identified in mammals as new modulators in cancer origination and progression involved in a broad range of biological processes. Long intergenic noncoding RNA
POU3F3
(linc-POU3F3) has been characterized as a highly conserved functional transcription regulator in esophageal squamous cell carcinoma. The contributions of this lincRNA to glioblastoma remain unknown. In this present study, we investigated the expression pattern and functional role of linc-
POU3F3
in
glioma
by using real-time PCR and gain-/loss-of-function studies. The results revealed that linc-
POU3F3
levels were extraordinarily associated with the tumor WHO grade. In related biochemical assays, overexpression of linc-
POU3F3
promotes cell viability and proliferation in
glioma
cells, whereas knockdown of linc-
POU3F3
showed the opposite effect. As expected, we also found that linc-
POU3F3
expression was negatively correlated with the mRNA level of
POU3F3
(the evolutionarily conserved neighbor gene of linc-POU3F3). Our results indicate that linc-
POU3F3
might affect
glioma
development via altering expression level of
POU3F3
, and lead us to believe that linc-
POU3F3
may also have a crucial regulatory role in
glioma
progression.
...
PMID:Functional linc-POU3F3 is overexpressed and contributes to tumorigenesis in glioma. 2544 82
Linc-
POU3F3
showed an up-regulated tendency and functioned as tumor promoter in
glioma
, esophageal cancer and colorectal cancer. There was no report about the expression pattern and clinical value of linc-
POU3F3
in hepatocellular carcinoma. Thus, the purpose of our study is to explore the clinical significance and biological role of linc-
POU3F3
in hepatocellular carcinoma. Our results suggested that levels of linc-
POU3F3
were dramatically increased in hepatocellular carcinoma tissues and cell lines compared with paired normal hepatic tissues and normal hepatic cell line, respectively. Levels of linc-
POU3F3
were positively correlated with clinical stage, tumor size, vascular invasion and metastasis. Moreover, high-expression of linc-
POU3F3
was an independent prognostic factor for hepatocellular carcinoma patients. The gain- and loss-of-function experiments showed that linc-
POU3F3
expression significantly promoted tumor cell proliferation, migration and invasion. In addition, linc-
POU3F3
expression was negatively correlated with
POU3F3
mRNA and protein expressions in hepatocellular carcinoma tissues, and negatively regulated
POU3F3
mRNA and protein expressions in hepatocellular carcinoma cells. In conclusion, our study supports the first evidence that linc-
POU3F3
plays an oncogenic role in hepatocellular carcinoma, and represents a potential therapeutic strategy for hepatocellular carcinoma patients.
...
PMID:Linc-POU3F3 is overexpressed in hepatocellular carcinoma and regulates cell proliferation, migration and invasion. 2990 46